Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN) gapped down before the market opened on Friday . The stock had previously closed at $11.59, but opened at $10.60. Anbio Biotechnology shares last traded at $10.9640, with a volume of 491 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

Anbio Biotechnology Price Performance

The stock has a 50-day moving average of $16.83.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.